Overall survival | p-value |
---|---|
FT Group | Ā |
āB-FT vs. NO-FT | 0.0003 |
āDA-FT vs. NO-FT | |
Age (years) | Ā |
āā„50 vs. < 50 | 0.0435 |
Smoking | Ā |
ā<20 pack-years vs. never smoker | 0.0272 |
āā„20 pack-years vs. never smoker | |
Type of Surgery | Ā |
āTLM vs. other | 0.0024* |
ātransoral bovie vs. other | |
ACE Score | Ā |
āModerate/ Severe vs. Mild/None | 0.0253* |
Combined T Stage | Ā |
āT1 vs. T3/T4 | 0.0440* |
āT2 vs. T3/T4 | |
Disease Free Survival | Ā |
FT Group | Ā |
āB-FT vs. NO-FT | 0.0004 |
āDA-FT vs. NO-FT | |
Age (years) | Ā |
āā„50 vs. < 50 | 0.0374 |
Smoking | Ā |
ā<20 pack-years vs. never smoker | 0.0346 |
āā„20 pack-years vs. never smoker | |
Type of Surgery | Ā |
āTLM vs. other | 0.0024* |
ātransoral bovie vs. other | |
ACE Score | Ā |
āModerate/Severe vs. Mild/None | 0.0675* |
Combined T Stage | Ā |
āT1 vs. T3/T4 | 0.0509* |
āT2 vs. T3/T4 | |
Distant Metastases Free Survival | Ā |
Group | Ā |
āB-FT vs. NO-FT | 0.9981 |
āDA-FT vs. NO-FT | |
Age (years) | Ā |
āā„50 vs. < 50 | 0.1060 |